Skip to content

Switching to TAF-based PrEP improves kidney and bone markers – but does it raise cardiovascular risk?

Danish research underlines the importance of monitoring kidney function in patients doing well on antiretrovirals

Image: phloxii/Shutterstock.com

Descovy is non-inferior to Truvada for daily PrEP

Brad Hare presenting at CROI 2019. Photo by Liz Highleyman.

Cocaine use associated with poor adherence to PrEP and dropping out of care

Smoking, cholesterol, blood pressure are more important causes of disease than HIV in people living with HIV

Improved liver function, but progressive kidney damage, among children on antiretroviral therapy in Ethiopia

Italian study shows growth in heart and kidney problems in people living with HIV

How safe is PrEP? Meta-analysis finds no increased risk of serious side-effects

How safe is PrEP? Meta-analysis finds no increased risk of serious side-effects

Older age and baseline kidney function, not ARV choice, are key risk factors for chronic kidney disease in people with HIV in Australian cohort